We studied the effectiveness of a computer program based on a mathematic model of warfarin dynamics in assisting with the initial phases of anticoagulation. In retrospective evaluations the program was successful in predicting prothrombin complex activity (PCA) responses for three different groups of subjects, indicating that the model is a good representation of the physiologic system. In a prospective evaluation of the program a computer-assisted group of 10 patients was compared with a control group of 10 patients who did not receive computer assistance. Because of the program's very conservative upper limits for warfarin dosage in the first few days of therapy, the computer-assisted patients required slightly more time (6 days), on the average, to first reach PCA values in the 20% to 30% therapeutic range than did the control patients (4.8 days). After the desired PCA had been achieved, however, the computer-assisted group remained within the therapeutic range for 83% of the time compared to only 60% for the control group. This difference was due primarily to much less overanticoagulation of the computer-assisted patients than of the controls.
made to predict individual anticoagulant dosage on the basis of characteristics such as body weight,5 no simple laboratory test or physical measurement has been found that can be used to estimate reliably a patient's maintenance dose before beginning therapy. In addition, the maximal effect of a single dose of warfarin on the prothrombin complex activity (PCA) develops 36 to 54 hr after the dose is given, so that the effects of daily dosing are cumulative and difficult to predict on an intuitive basis.
Methods for initiating oral anticoagulation should minimize the time required to achieve steady-state PCA values within the therapeutic range while protecting the patient from the possibility of overdosage and hemorrhage. It is difficult to evaluate the degree to which conventional methods achieve this goal, since no detailed studies have been reported on variations in the PCA during the initiation of oral anticoagulation. There are, however, several studies that document the fact that PCA control tends to be suboptimal even during the maintenance phase. Brotman2 found that under most circumstances one could expect to have a patient within the therapeutic range no more than 55% to 65% of the time and Mosely et al.6 reported that at any given time only 65% of their patients were within therapeutic limits. Shapiro et al." found that patients treated with oral drug were within the therapeutic range 71% of the time, but the therapeutic limits for PCA they used (11% to 26%) were much wider than is usually accepted at present. Pollard et al."
reported results similar to those of Shapiro et al. The large variations in PCA that occur during long-term anticoagulation underscore the difficulties of dosage determination during the initiation of anticoagulation when there is no previous experience from which to predict a patient's response. As a result, the initial phase of anticoagulation is often unsatisfactory.
Despite the difficulties it is very important to identify an appropriate maintenance dose as soon as possible after beginning therapy. Inadequate anticoagulation may increase the risk of thrombosis, while overanticoagulation carries the risk of severe hemorrhage. Because of the importance and difficulty of achieving adequate anticoagulation rapidly and safely, an attempt to use a more rigorous method for estimating anticoagulant dosage during initiation phases is justified.
Several groups have recently reported methods that correlate either the time required to reach a specified level of anticoagulation during the loading phase"' 13 or the area under the prothrombin time-dose curve" with the ultimately required maintenance dose. While these methods are an important advance, they have not proved to be suitable for all patients.4' 5 In another approach, computer models have been used to predict PCA response to warfarin during retrospective study of the initial phase of anticoagulation"' 17 and prospectively during long-term anticoagulation,3' 18 but they have not been used as an adjunct during the initiation of oral anticoagulant therapy. Mathematic models suitable for assisting in initial anticoagulation have been described,7 but none has been used in a computer program to assist the physician.
None of the reported models provides a mechanistic framework potentially useful for the study of other aspects of warfarin pharmacology, such as interactions of warfarin with other drugs.
We have approached the problem by proposing a model8' 9" 11 warfarin effect on plasma prothrombin activity that is based in part on the enzyme-substrate formulation of Sellers and Koch-Wesser." Our model assumes rapid absorption of warfarin so that the total body warfarin at a time t is given by also likely that the patients in group R-3 were exposed to more factors that affect warfarin response, such as the presence of interacting drugs, than were the normal subjects of group R-2.
The generally good agreement between the predicted and observed PCA values in all three retrospective trials established the model as a good representation of the physiologic system with adequate reliability to justify a prospective trial in patients.
Prospective evaluation of program performance
Program assistance was provided for a total of 10 patients undergoing initial anticoagulation. All but one patient considered in this phase of the study were receiving anticoagulant therapy postoperatively on the cardiac surgery service at UMMC. These patients are routinely placed on prolonged therapy after coronary artery bypass surgery or implantation of prosthetic heart valves. The remaining patient was anticoagulated after acute pulmonary embolism. The house staff responsible for the patients' clinical care decided when oral anticoagulant should be initiated.
Patients were considered eligible for our study if: (1) they had PCA of 70% or more at the onset of oral anticoagulation, (2) they were afebrile, and (3) they had received either no warfarin or not more than two 5-mg doses at the time we were informed of their availability for study.
A control group (group P-C) of 10 patients was anticoagulated without computer assistance. These patients were matched with the computer-assisted patients on the basis of age and diagnostic category and were treated on the same services as the computer-assisted group.
Thus, the control group also consisted of nine patients who had undergone heart surgery and one patient anticoagulated for thrombophlebitis. Mean age for each group was 52 yr.
Each day, shortly after PCA values were received from the anticoagulation laboratory, we placed sheets in the order books informing the house staff of the PCA for that day and the program's current dosage recommendations. The house staff either prescribed the recommended dosage or modified it on the basis of clinical judgement. Fig. 3 shows the recommended warfarin doses for one of these patients along with the computer-predicted and observed PCA values. The responses of the remaining patients were on the same order. The number of days required to bring the PCA into the therapeutic (20% to 30%) range and the percentage of subsequent days within the therapeutic range were computed for each member of the computer-assisted and control groups (Table III) . When distributional requirements appeared to be satisfied, the results were tested for significance by Student's t test. Otherwise, the Wilcoxon rank-sum test was used. The average number of days required to first reach the therapeutic range was greater for the computer-assisted than for the control patients (P < 0.05 by Student's t test). This additional time, however, did not prolong patients' hospital stays; continued hospitalization was required for other reasons. More importantly, after once having reached the therapeutic range, the program-assisted group remained within the therapeutic range for a much larger percentage of the time (P < 0.01). This indicates that the maintenance dose was estimated with much greater accuracy in the computer-assisted group.
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Control Computer-assisted (group P-C) (group P-1) termine the method's range of applicability, results thus far support our belief that the computer-assisted approach described here may lead to improved control of oral anticoagulation.
